Gene D Morse Selected Research

amprenavir (Agenerase)

5/2007	Compartmental pharmacokinetic analysis of oral amprenavir with secondary peaks.
8/2005	Amprenavir and efavirenz pharmacokinetics before and after the addition of nelfinavir, indinavir, ritonavir, or saquinavir in seronegative individuals.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gene D Morse Research Topics

Disease

29	Acquired Immunodeficiency Syndrome (AIDS) 10/2022 - 06/2003
9	HIV Infections (HIV Infection) 01/2020 - 01/2003
8	Infections 01/2020 - 01/2003
8	Opioid-Related Disorders (Opiate Addiction) 01/2020 - 12/2006
6	Substance-Related Disorders (Drug Abuse) 01/2016 - 12/2006
5	Coinfection 01/2020 - 10/2007
5	Drug-Related Side Effects and Adverse Reactions 11/2012 - 05/2007
4	Viremia 10/2022 - 01/2007
3	Malaria 05/2014 - 01/2011
3	Substance Withdrawal Syndrome (Withdrawal Symptoms) 01/2010 - 01/2006
2	Body Weight (Weight, Body) 01/2017 - 05/2007
2	Communicable Diseases (Infectious Diseases) 05/2014 - 09/2007
2	Hyperbilirubinemia 04/2014 - 02/2013
2	Alcoholism (Alcohol Abuse) 03/2014 - 05/2012
1	Neoplasms (Cancer) 10/2020
1	Glycosuria 01/2020
1	AIDS-Related Lymphoma (Lymphoma, AIDS Related) 01/2020
1	Hepatitis C 01/2020
1	Hypophosphatemia 01/2020
1	Fanconi Syndrome (Syndrome, Fanconi) 01/2020
1	Fibrosis (Cirrhosis) 01/2020
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2020
1	Proteinuria 01/2020
1	Kidney Diseases (Kidney Disease) 01/2019
1	Chronic Renal Insufficiency 01/2019
1	Necrosis 01/2018
1	Inflammation (Inflammations) 01/2018
1	Familial Hypophosphatemia (Phosphate Diabetes) 01/2017
1	Hypercholesterolemia 01/2016
1	Diabetes Complications 01/2016
1	Lipodystrophy 01/2016
1	Dyslipidemias (Dyslipidemia) 01/2016
1	Hypertriglyceridemia 01/2016

Drug/Important Bio-Agent (IBA)

15	efavirenz (Sustiva)FDA Link 01/2019 - 06/2003
12	Pharmaceutical PreparationsIBA 01/2018 - 12/2003
10	Atazanavir Sulfate (Reyataz)FDA Link 01/2019 - 03/2006
9	Ritonavir (Norvir)FDA Link 01/2020 - 08/2005
7	Protease Inhibitors (Protease Inhibitor)IBA 01/2019 - 03/2006
7	Buprenorphine (Subutex)FDA LinkGeneric 02/2012 - 12/2006
6	Opioid Analgesics (Opioids)IBA 02/2012 - 01/2006
5	Tenofovir (Viread)FDA Link 01/2020 - 09/2015
5	Methadone (Dolophine)FDA LinkGeneric 01/2020 - 01/2006
5	NucleosidesIBA 11/2010 - 01/2003
4	Cytochrome P-450 CYP2B6 (CYP2B6)IBA 01/2020 - 09/2010
4	Indinavir (Crixivan)FDA Link 11/2010 - 06/2003
4	Reverse Transcriptase InhibitorsIBA 01/2010 - 01/2003
4	Lopinavir FDA Link 11/2007 - 12/2006
4	Delavirdine (Rescriptor)FDA Link 12/2006 - 01/2003
4	Nelfinavir (Viracept)FDA Link 12/2006 - 03/2004
3	Nevirapine (Viramune)FDA Link 01/2021 - 01/2010
3	abacavir (Ziagen)FDA Link 01/2017 - 06/2003
3	Opiate AlkaloidsIBA 01/2010 - 12/2006
2	DNA (Deoxyribonucleic Acid)IBA 10/2022 - 11/2010
2	RNA (Ribonucleic Acid)IBA 11/2020 - 11/2010
2	paritaprevirIBA 01/2020 - 01/2017
2	Phosphates (Orthophosphate)IBA 01/2020 - 01/2017
2	Emtricitabine (Emtriva)FDA Link 01/2019 - 09/2015
2	BilirubinIBA 01/2018 - 04/2014
2	LipidsIBA 01/2016 - 06/2007
2	Amodiaquine (Camoquin)FDA Link 05/2014 - 01/2012
2	ArtesunateIBA 05/2014 - 01/2012
2	Disulfiram (Antabuse)FDA Link 03/2014 - 05/2012
2	Human immunodeficiency virus 1 p16 proteaseIBA 08/2010 - 11/2007
2	amprenavir (Agenerase)FDA Link 05/2007 - 08/2005
1	Tamoxifen FDA LinkGeneric 10/2022
1	Vorinostat FDA Link 10/2022
1	Histones (Histone)IBA 10/2022
1	dasabuvirIBA 01/2020
1	Ribavirin (Virazole)FDA LinkGeneric 01/2020
1	Antiviral Agents (Antivirals)IBA 01/2020
1	Rituximab (Mabthera)FDA Link 01/2020
1	ombitasvirIBA 01/2020
1	Raltegravir Potassium FDA Link 01/2020
1	lamivudine drug combination abacavir FDA Link 01/2019
1	EnzymesIBA 01/2018
1	3- (2- iodoacetamido)- 2,2,5,5- tetramethyl- 1- pyrrolidinyloxyl (IPSL)IBA 01/2018
1	C-Reactive ProteinIBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	Interleukin-6 (Interleukin 6)IBA 01/2018
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2018
1	N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA 12/2017
1	Phosphorus (Red Phosphorus)IBA 01/2017
1	Thymidine Monophosphate (TMP)IBA 01/2017
1	Scavenger Receptors (Scavenger Receptor)IBA 03/2016
1	ITX-5061IBA 03/2016
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2016
1	Anti-Retroviral Agents (Antiretroviral Agents)IBA 01/2016
1	Fibric Acids (Fibrates)IBA 01/2016
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2016
1	Niacin (Nicotinic Acid)FDA LinkGeneric 01/2016

Therapy/Procedure

17	Therapeutics 10/2022 - 12/2003
4	Art Therapy 01/2012 - 05/2007
3	Highly Active Antiretroviral Therapy (HAART) 11/2020 - 01/2011
3	Drug Therapy (Chemotherapy) 10/2020 - 03/2014
1	Brachytherapy 10/2020
1	Duration of Therapy 01/2020
1	Polypharmacy 01/2019
1	Transplantation 03/2016
1	Liver Transplantation 03/2016
1	Glycemic Control 01/2016